» Articles » PMID: 28006013

Procarcinogens - Determination and Evaluation by Yeast-Based Biosensor Transformed with Plasmids Incorporating RAD54 Reporter Construct and Cytochrome P450 Genes

Overview
Journal PLoS One
Date 2016 Dec 23
PMID 28006013
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In Vietnam, a great number of toxic substances, including carcinogens and procarcinogens, from industrial and agricultural activities, food production, and healthcare services are daily released into the environment. In the present study, we report the development of novel yeast-based biosensor systems to determine both genotoxic carcinogens and procarcinogens by cotransformation with two plasmids. One plasmid is carrying human CPR and CYP (CYP3A4, CYP2B6, or CYP2D6) genes, while the other contains the RAD54-GFP reporter construct. The three resulting coexpression systems bearing both CPR-CYP and RAD54-GFP expression cassettes were designated as CYP3A4/CYP2B6/CYP2D6 + RAD54 systems, respectively and used to detect and evaluate the genotoxic potential of carcinogens and procarcinogens by selective activation and induction of both CPR-CYP and RAD54-GFP expression cassettes in response to DNA damage. Procarcinogens were shown to be predominantly, moderately or not bioactivated by one of the CYP enzymes and thus selectively detected by the specific coexpression system. Aflatoxin B1 and benzo(a)pyrene were predominantly detected by the CYP3A4 + RAD54 system, while N-nitrosodimethylamine only moderately activated the CYP2B6 + RAD54 reporter system and none of them was identified by the CYP2D6 + RAD54 system. In contrast, the genotoxic carcinogen, methyl methanesulfonate, was detected by all systems. Our yeast-reporter system can be performed in 384-well microplates to provide efficient genotoxicity testing to identify various carcinogenic compounds and reduce chemical consumption to about 53% as compared with existing 96-well genotoxicity bioassays. In association with a liquid handling robot, this platform enables rapid, cost-effective, and high-throughput screening of numerous analytes in a fully automated and continuous manner without the need for user interaction.

Citing Articles

Engineering Saccharomyces cerevisiae for medical applications.

Maneira C, Chamas A, Lackner G Microb Cell Fact. 2025; 24(1):12.

PMID: 39789534 PMC: 11720383. DOI: 10.1186/s12934-024-02625-5.


Sensing chemical-induced DNA damage using CRISPR/Cas9-mediated gene-deletion yeast-reporter strains.

Yamamoto K, Tochikawa S, Miura Y, Matsunobu S, Hirose Y, Eki T Appl Microbiol Biotechnol. 2024; 108(1):188.

PMID: 38300351 PMC: 10834598. DOI: 10.1007/s00253-024-13020-w.


Anxiety and depressive symptoms in pregnancy predict low birth weight differentially in male and female infants-findings from an urban pregnancy cohort in India.

Chandra P, Bajaj A, Desai G, Satyanarayana V, Sharp H, Ganjekar S Soc Psychiatry Psychiatr Epidemiol. 2021; 56(12):2263-2274.

PMID: 34114109 DOI: 10.1007/s00127-021-02106-9.


Yeast-Based Biosensors: Current Applications and New Developments.

Martin-Yken H Biosensors (Basel). 2020; 10(5).

PMID: 32413968 PMC: 7277604. DOI: 10.3390/bios10050051.


Overview of Piezoelectric Biosensors, Immunosensors and DNA Sensors and Their Applications.

Pohanka M Materials (Basel). 2018; 11(3).

PMID: 29562700 PMC: 5873027. DOI: 10.3390/ma11030448.

References
1.
Lundin C, North M, Erixon K, Walters K, Jenssen D, Goldman A . Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks. Nucleic Acids Res. 2005; 33(12):3799-811. PMC: 1174933. DOI: 10.1093/nar/gki681. View

2.
Guengerich F . Cytochrome p450 and chemical toxicology. Chem Res Toxicol. 2007; 21(1):70-83. DOI: 10.1021/tx700079z. View

3.
Donato M, Jimenez N, Castell J, Gomez-Lechon M . Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos. 2004; 32(7):699-706. DOI: 10.1124/dmd.32.7.699. View

4.
Afanassiev V, Sefton M, Anantachaiyong T, Barker G, Walmsley R, Wolfl S . Application of yeast cells transformed with GFP expression constructs containing the RAD54 or RNR2 promoter as a test for the genotoxic potential of chemical substances. Mutat Res. 2000; 464(2):297-308. DOI: 10.1016/s1383-5718(99)00209-0. View

5.
Cahill P, Knight A, Billinton N, Barker M, Walsh L, Keenan P . The GreenScreen genotoxicity assay: a screening validation programme. Mutagenesis. 2004; 19(2):105-19. DOI: 10.1093/mutage/geh015. View